Nitric oxide inhibits hetero-adhesion of cancer cells to endothelial cells: Restraining circulating tumor cells from initiating metastatic cascade

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Lu, Yusheng ^a   Yu, Ting ^a   Liang, Haiyan ^a   Wang, Jichuang ^a   Xie, Jingjing ^a   Shao, Jingwei ^a   Gao, Yu ^a   Yu, Suhong ^a   Chen, Shuming ^b   Wang, Lie ^b   Jia, Lee ^a  

^a FUZHOU UNIVERSITY   (China)

^b FUZHOU GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CYTOKINE; DRUG DERIVATIVE; ENZYME INHIBITOR; GUANYLATE CYCLASE; HEMOGLOBIN; NITRIC OXIDE; NITRIC OXIDE DONOR; S NITROSOCAPTOPRIL; S-NITROSOCAPTOPRIL; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CELL CYCLE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; METASTASIS; PATHOLOGY; TUMOR CELL LINE; TUMOR EMBOLISM; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; VASODILATATION;

CAPTOPRIL; CELL ADHESION; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GENE EXPRESSION; GUANYLATE CYCLASE; HEMOGLOBINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; NITRIC OXIDE; NITRIC OXIDE DONORS; VASCULAR CELL ADHESION MOLECULE-1; VASODILATION;

EID: 84896371849     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04344     Document Type: Article

References (50)

1. Nguyen, D. X., Bos, P. D. & Massague, J. Metastasis: from dissemination to organspecificcolonization. Nat Rev Cancer 9, 274-284 (2009).
2. Sethi, N. & Kang, Y. Unravelling the complexity of metastasis - molecularunderstanding and targeted therapies. Nat Rev Cancer 11, 735-748 (2011).
3. Plaks, V., Koopman, C. D. & Werb, Z. Cancer. Circulating tumor cells. Science341, 1186-1188 (2013).
4. Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science331, 1559-1564 (2011).
5. Alby, L. & Auerbach, R. Differential adhesion of tumor cells to capillaryendothelial cells in vitro. Proc Natl Acad of Sci USA 81, 5739-5743 (1984). (Pubitemid 14023839)
6. Dejana, E. et al. Interleukin 1 promotes tumor cell adhesion to cultured humanendothelial cells. J Clin Invest 82, 1466 (1988).
7. Rice, G. E. & Bevilacqua, M. P. An inducible endothelial cell surface glycoproteinmediates melanoma adhesion. Science 246, 1303-1306 (1989). (Pubitemid 20066715)
8. Meager, A. Cytokine regulation of cellular adhesion molecule expression ininflammation. Cytokine Growth Factor Rev 10, 27-39 (1999). (Pubitemid 29230850)
9. Taichman, D. et al. Tumor cell surface alpha 4 beta 1 integrin mediates adhesion tovascular endothelium: demonstration of an interaction with the N-terminaldomains of INCAM-110/VCAM-1. Cell Regul 2, 347 (1991).
10. Phillips, M. L. et al. ELAM-1 mediates cell adhesion by recognition of acarbohydrate ligand, sialyl-Lex. Science 250, 1130-1132 (1990). (Pubitemid 120031820)
11. Zen, K. et al. CD44v4 is a major E-selectin ligand that mediates breast cancer celltransendothelial migration. PLoS One 3, e1826 (2008).
12. Honn, K. V. & Tang, D. G. Adhesion molecules and tumor cell interaction withendothelium and subendothelial matrix. Cancer Metastasis Rev 11, 353-375(1992).
13. Lauri, D., Needham, L., Martin-Padura, I. & Dejana, E. Tumor cell adhesion toendothelial cells: endothelial leukocyte adhesion molecule-1 as an inducibleadhesive receptor specific for colon carcinoma cells. J Natl Cancer Inst 83, 1321-1324 (1991).
14. Takada, A. et al. Contribution of carbohydrate antigens sialyl Lewis A and sialylLewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res53, 354-361 (1993). (Pubitemid 23031849)
15. Furchgott, R. F. & Zawadzki, J. V. The obligatory role of endothelial cells in therelaxation of arterial smooth muscle by acetylcholine. Nature 288, 373-376(1980). (Pubitemid 11169009)
16. Palmer, R. M., Ferrige, A. G. & Moncada, S. Nitric oxide release accounts for thebiological activity of endothelium-derived relaxing factor. Nature 327, 524-526(1987). (Pubitemid 17085822)
17. Loscalzo, J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis.Circ Res 88, 756-762 (2001). (Pubitemid 32429970)
18. Jia, L. & Stamler, J. S. Dual actions of S-nitrosylated derivative of vasoactiveintestinal peptide as a vasoactive intestinal peptide-like mediator and a nitricoxide carrier. Eur J Pharmacol 366, 79-86 (1999). (Pubitemid 29076724)
19. Jia, L. & Wong, H. In vitro and in vivo assessment of cellular permeability andpharmacodynamics of S-nitrosylated captopril, a nitric oxide donor. Br JPharmacol 134, 1697-1704 (2001). (Pubitemid 34038103)
20. Nakaki, T., Nakayama, M. & Kato, R. Inhibition by nitric oxide and nitric oxideproducingvasodilators of DNA synthesis in vascular smooth muscle cells. Eur JPharmacol 189, 347-353 (1990).
21. Kubes, P., Suzuki, M. & Granger, D. Nitric oxide: an endogenous modulator ofleukocyte adhesion. Proc Natl Acad of Sci USA 88, 4651-4655 (1991). (Pubitemid 21914599)
22. Tsao, P. S., McEvoy, L. M., Drexler, H., Butcher, E. C. & Cooke, J. P. Enhancedendothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine.Circulation 89, 2176-2182 (1994). (Pubitemid 24142796)
23. Jia, L. et al. Effect of nitric oxide on cytotoxicity of Taxol: enhanced Taxoltranscellular permeability. Biochem Pharmacol 66, 2193-2199 (2003). (Pubitemid 37377864)
24. Xu, W., Liu, L. Z., Loizidou, M., Ahmed, M.&Charles, I. G. The role of nitric oxidein cancer. Cell Res 12, 311-320 (2002).
25. Jia, L.&Blantz, R. C. The effects of S-nitrosocaptopril on renal filtration and bloodpressure in rats. Eur J Pharmacol 354, 33-41 (1998). (Pubitemid 28410228)
26. Loscalzo, J., Smick, D., Andon, N. & Cooke, J. S-nitrosocaptopril. I. Molecularcharacterization and effects on the vasculature and on platelets. J Pharmacol ExpTher 249, 726-729 (1989). (Pubitemid 19166649)
27. Lin, M., Yang, X., Wang, J., Jia, B. & Jia, L. Inhibitory effects of S-nitrosocaptoprilon vasomotor tone. Acta Pharmacol Sin 19, 485 (1998).
28. Tsui, D. Y., Gambino, A. & Wanstall, J. C. S-nitrosocaptopril: in vitrocharacterization of pulmonary vascular effects in rats. Br J Pharmacol 138, 855-864 (2003). (Pubitemid 36390642)
29. Jia, L. & Furchgott, R. F. Inhibition by sulfhydryl compounds of vascularrelaxation induced by nitric oxide and endothelium-derived relaxing factor.J Pharmacol Exp Ther 267, 371-378 (1993). (Pubitemid 23325030)
30. Furchgott, R. F. The 1996 Albert Lasker Medical Research Awards. The discoveryof endothelium-derived relaxing factor and its importance in the identification ofnitric oxide. JAMA 276, 1186-1188 (1996). (Pubitemid 26329750)
31. Jaffe, E. A., Nachman, R. L., Becker, C. G. & Minick, C. R. Culture of humanendothelial cells derived from umbilical veins. Identification by morphologic andimmunologic criteria. J Clin Invest 52, 2745-2756 (1973).
32. Peichev, M. et al. Expression of VEGFR-2 and AC133 by circulating humanCD341 cells identifies a population of functional endothelial precursors. Blood95, 952-958 (2000). (Pubitemid 30062717)
33. Ricci-Vitiani, L. et al. Tumour vascularization via endothelial differentiation ofglioblastoma stem-like cells. Nature 468, 824-828 (2010).
34. Miettinen, M., Lindenmayer, A. E. & Chaubal, A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-evaluation of their specificityand sensitivity in the diagnosis of vascular tumors and comparison with vonWillebrand factor. Mod Pathol 7, 82-90 (1994).
35. Bevilacqua, M. P., Pober, J. S., Wheeler, M. E., Cotran, R. S. & Gimbrone Jr, M. A.Interleukin 1 acts on cultured human vascular endothelium to increase theadhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte celllines. J Clin Invest 76, 2003-2011 (1985). (Pubitemid 16196076)
36. Amano, M., Takahashi, M., Kosaka, T. & Kinoshita, M. Differential inhibition ofplatelet aggregation and calcium mobilization by nitroglycerin and stabilizednitric oxide. J Cardiovasc Pharmacol 24, 860-866 (1994).
37. Cooke, J. P., Andon, N. & Loscalzo, J. S-nitrosocaptopril. II. Effects on vascularreactivity. J Pharmacol Exp Ther 249, 730-734 (1989).
38. Nakae, I., Takahashi, M., Kinoshita, T., Matsumoto, T.&Kinoshita, M. The effectsof S-nitrosocaptopril on canine coronary circulation. J Pharmacol Exp Ther 274, 40-46 (1995).
39. Shaffer, J. E. et al. The hemodynamic effects of S-nitrosocaptopril in anesthetizeddogs. J Pharmacol Exp Ther 256, 704-709 (1991).
40. Jia, L., Pei, R., Lin, M. & Yang, X. Acute and subacute toxicity and efficacy of Snitrosylatedcaptopril, an ACE inhibitor possessing nitric oxide activities. FoodChem Toxicol 39, 1135-1143 (2001). (Pubitemid 33030226)
41. Jia, L., Wu, C. C., Guo, W. & Young, X. Antiangiogenic effects of Snitrosocaptoprilcrystals as a nitric oxide donor. Eur J Pharmacol 391, 137-144(2000). (Pubitemid 30138090)
42. Tsao, P. S., Buitrago, R., Chan, J. R. & Cooke, J. P. Fluid flow inhibits endothelialadhesiveness nitric oxide and transcriptional regulation of VCAM-1. Circulation94, 1682-1689 (1996). (Pubitemid 26320275)
43. De Caterina, R. et al. Nitric oxide decreases cytokine-induced endothelialactivation. Nitric oxide selectively reduces endothelial expression of adhesionmolecules and proinflammatory cytokines. J Clin Invest 96, 60 (1995).
44. Jordan, B. F. et al. Captopril and S-nitrosocaptopril as potent radiosensitizers: Comparative study and underlying mechanisms. Cancer Lett 293, 213-219(2010).
45. Gay, L. J. & Felding-Habermann, B. Contribution of platelets to tumourmetastasis. Na Rev Cancer 11, 123-134 (2011).
46. Jia, L. et al. EDRF-like activity and anticancer spectrum of JS-K, a noveldiazeniumdiolate nitric oxide donor. In: Proc. Am. Assoc. Cancer Res 44, 1059(2003).
47. Jia, L., Young, X. & Guo, W. Physicochemistry, pharmacokinetics, andpharmacodynamics of S-nitrosocaptopril crystals, a new nitric oxide donor.J Pharm Sci 88, 981-986 (1999). (Pubitemid 29480587)
48. Garthwaite, J. et al. Potent and selective inhibition of nitric oxide-sensitiveguanylyl cyclase by 1H-[1, 2, 4]oxadiazolo[4, 3-A]quinoxalin-1-one. MolPharmacol 48, 184-188 (1995).
49. Wang, J. et al. Synthesis, Spectral Characterization, and In Vitro Cellular Activitiesof Metapristone, a Potential Cancer Metastatic Chemopreventive Agent Derivedfrom Mifepristone (RU486). AAPS J, DOI: 10.1208/s12248-013-9559-2 (2014).
50. Shao, J. et al. Intracellular distribution and mechanisms of actions ofphotosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL againsthuman hepatocellular carcinoma HepG2 cells. Cancer Lett 330, 49-56 (2013).